The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines

TY - JOUR

T1 - The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines

AU - Dranitsaris, George

AU - Rayson, Daniel

AU - Vincent, Mark

AU - Chang, Jose

AU - Gelmon, Karen

AU - Sandor, David

AU - Reardon, Greg

N1 - Funding Information: Conflict of interest statement: Funding for this study was provided by an unrestricted research grant from Schering-Plough Corp. The primary authors had full access to the data in the study and had the final responsibility for the decision to submit the paper. George Dranitsaris and Greg Reardon received consultancy fees from Schering-Plough Corp. At the time of this study, David Sandor was an employee of Schering-Plough Corp. None of the other co-authors have a conflict of interest to declare.

PY - 2008/2

Y1 - 2008/2

UR - http://www.scopus.com/inward/record.url?scp=38649099422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649099422&partnerID=8YFLogxK

U2 - 10.1007/s10549-007-9803-5

DO - 10.1007/s10549-007-9803-5

M3 - Article

C2 - 17978870

AN - SCOPUS:38649099422

SN - 0167-6806

VL - 107

SP - 443

EP - 450

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -